Inflammatory biomarkers and plasma lipidomics after raltegravir plus TDF/FTC initiation in people with HIV: A longitudinal pilot study
Biomolecules and Biomedicine · 19.10.2026
DOI: 10.17305/bb.2026.14928 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules and Biomedicine, online erschienen am 19.10.2026. Verfasst von Jose-Ramon Blanco und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Hospital Universitario San Pedro, Logroño, La Rioja, Spain; Centro de Investigación Biomédica de La Rioja (CIBIR),…. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Persistent inflammation and altered lipid metabolism are linked to comorbidities in people with human immunodeficiency virus (HIV), yet their progression after initiating antiretroviral therapy (ART) is not fully understood. This exploratory, uncontrolled pilot study investigated longitudinal changes in biomarkers and plasma lipidomics in 11 ART-naïve adults starting raltegravir plus tenofovir disoproxil fumarate/emtricitabine. Circulating biomarkers were measured, and untargeted plasma lipidomics was performed using ultra-high-performance liquid chromatography–mass spectrometry at baseline and at a follow-up visit near week 48 (range: 47.7–61.9 weeks). Within-participant changes were analyzed using paired Wilcoxon signed-rank tests, with Benjamini–Hochberg false discovery rate (FDR) correction applied separately to biomarker and lipidomic datasets. Paired effect sizes and 95% confidence intervals were also estimated. All participants achieved virological suppression. After FDR correction, interleukin-10 (IL-10) concentrations increased, and soluble cluster of differentiation 163 (sCD163) concentrations decreased (both q = 0.019). However, none of the 490 lipid features remained significant after FDR correction. Twenty-six features showed large absolute paired Hedges' effect-size estimates (|gz| ≥ 0.80), with 24 positive and two negative estimates. These findings demonstrate longitudinal changes in IL-10 and sCD163 following ART initiation. The lipidomic results, however, are considered hypothesis-generating. Due to the absence of a comparator group, these changes cannot be definitively attributed to the specific ART regimen. Larger, controlled studies are necessary to confirm reproducibility and clinical relevance.
Autor:innen und Institutionen
- Department of Infectious Diseases, Hospital Universitario San Pedro, Logroño, La Rioja, Spain; Centro de Investigación Biomédica de La Rioja (CIBIR), Fundación Rioja Salud, Logroño, La Rioja, Spain; Grupo de Investigaci…
- Infectious Diseases Section, Department of Internal Medicine, Hospital Universitario Reina Sofía, Murcia, Spain; Instituto Murciano de Investigación Biosanitaria (IMIB), Murcia, Spain; Department of Medicine, Universida…
- Department of Infectious Diseases, Hospital Universitario Ramón y Cajal, Madrid, Spain; Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain; Department of Medicine and Medical Specialties, Univers…
- Infectious Diseases Area (CIBERINFEC), Centro de Investigación Biomédica en Red (CIBER), Madrid, Spain; HIV Unit, Hospital Universitario 12 de Octubre, Madrid, Spain; Instituto de Investigación Hospital 12 de Octubre, M…
- Rubió Metabolomics, Derio, Spain.
- Infectious Diseases Area (CIBERINFEC), Centro de Investigación Biomédica en Red (CIBER), Madrid, Spain; Department of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madri…
Zitieren
APA
Blanco, J. R., Bernal-Morell, E., Moreno, S., Rial-Crestelo, D., Martínez-Vives, M., Alonso, C., Pérez-Latorre, L., Reus Bañuls, S., Romero, L., Ortiz de Barrón, X. C., Perez-Martinez, L., & CoRIS cohort (2026). Inflammatory biomarkers and plasma lipidomics after raltegravir plus TDF/FTC initiation in people with HIV: A longitudinal pilot study. Biomolecules and Biomedicine. https://doi.org/10.17305/bb.2026.14928
Vancouver
Blanco JR, Bernal-Morell E, Moreno S, Rial-Crestelo D, Martínez-Vives M, Alonso C, et al. Inflammatory biomarkers and plasma lipidomics after raltegravir plus TDF/FTC initiation in people with HIV: A longitudinal pilot study. Biomolecules and Biomedicine. 2026. doi:10.17305/bb.2026.14928
BibTeX
@article{Blanco2026,
author = {Blanco, Jose-Ramon and Bernal-Morell, Enrique and Moreno, Santiago and Rial-Crestelo, David and Martínez-Vives, María and Alonso, Cristina and Pérez-Latorre, Leire and Reus Bañuls, Sergio and Romero, Lourdes and Ortiz de Barrón, Xabier Camino and Perez-Martinez, Laura and CoRIS cohort, CoRIS cohort},
title = {Inflammatory biomarkers and plasma lipidomics after raltegravir plus TDF/FTC initiation in people with HIV: A longitudinal pilot study},
journal = {Biomolecules and Biomedicine},
year = {2026},
doi = {10.17305/bb.2026.14928}
}
EUVIMED